Related Experiment Video
Updated: Jun 18, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Duration of hepatitis E viremia in pregnancy
Nargis Begum1, Sunil Kumar Polipalli, Syed Akhtar Husain
1PCR Hepatitis Laboratory, Department of Medicine, Maulana Azad Medical College, University of Delhi, New Delhi, India. nargisbegum18@gmail.com
Objective:
To investigate the duration of hepatitis E virus (HEV) infection in pregnant and non-pregnant women with acute viral hepatitis (AVH) or fulminant hepatic failure (FHF).
Methods:
A prospective study conducted with 20 pregnant women with AVH, 20 non-pregnant women with AVH, 10 pregnant women with FHF, and 9 non-pregnant women with FHF-all with HEV infection. The women were followed up on day 7, 15, 30, 60, and 90 following recruitment for the presence of HEV-RNA.
Results:
Of the 59 patients with HEV infection, only 2 (3.4%) revealed HEV viremia at day 30 and none of the patients was viremic at day 60 and day 90. The proportion of HEV viremia in pregnant women with AVH and FHF at day 15 was significantly higher than in non-pregnant women (88.3% vs 27.6%; P<0.001). Similarly, HEV viremia among patients with AVH was significantly higher in pregnant women compared with non-pregnant women (100% vs 55%; P<0.001).
Conclusion:
HEV viremia may be prolonged in pregnancy.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Yellow Fever
Poliomyelitis
Hepatic Encephalopathy
